Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-01-17
1997-02-25
Wu, Shean C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514443, 514444, 514448, 548525, 549 33, 549 58, A61K 3140, A61K 3138, C07D40910
Patent
active
056059248
ABSTRACT:
The present invention relates to compounds of the formula ##STR1## where X is a bond or --CH2--;
REFERENCES:
patent: 4133814 (1979-01-01), Jones et al.
patent: 4358593 (1982-11-01), Jones et al.
patent: 4418068 (1983-11-01), Jones
patent: 4729999 (1988-03-01), Young
patent: 4894373 (1990-01-01), Young
patent: 4970237 (1990-11-01), Jensen et al.
patent: 5464845 (1995-11-01), Black et al.
patent: 5482949 (1996-01-01), Black et al.
patent: 5534527 (1996-07-01), Black et al.
patent: 7920933 (1992-07-01), Black et al.
patent: 7995222 (1992-12-01), Black et al.
Williams, et al., Journal of Bone and Mineral Research, 6 (1991).
FDC Reports, T&G 11, Mar. 30, 1992.
Jones, et al., J. Med. Chem., 27, 1057-1066 (1984).
Feldmann, et al., Bone and Mineral, 7, 245-254 (1989).
"Tamoxifen Trial Restricted", SCRIP No. 1702 Mar. 20, 1992, p. 22.
Jordan, et al., Brease Cancer Research Treatment, 10:31-35 (1987).
Beall, et al., Calcif Tissue Int., 36: 123-125 (1984).
Turner, et al., Journal of Bone and Mineral Research, 2, No. 5, 449-456 (1987).
Williams, et al., Bone and Mineral, 14, 205-220 (1991).
U.S. Application No. 07/920,933 Black, et al. filed Jul. 28, 1992.
U.S. Application No. 07/995,222 Black et al. filed Dec. 22, 1992.
Turner, et al., Endocrinology, 122, No. 3, 1146-1150 (1988).
Love, et al., The New England Journal of Medicine, 326, No. 13, 852-856 (1992).
Breckenridge, et al., Lipids, 22, No. 7, 505-512 (1987).
Lazier, et al., Biochem. Cell Biol., 68, 210-217 (1990).
Lobo, J. Clin. Endocrinol. Metab., 73, No. 5, 925-930 (1991).
Love, et al., Ann. Intern. Med., 115, No. 11, 860-864 (1991).
Walsh, et al., N. Engl. J. Med., 325, No. 17, 1196-1204 (1991).
Bagdade, et al., J. Clin. Endocrinol. Metab., 70, No. 4, 1132-1135 (1990).
Love, et al., J. Natl. Cancer Inst., 82, No. 116, 1327-1332 (1990).
Teo, et al., J. Med. Chem., 35, 1330-1339 (1992.
Cypriani, et al., J. Steroid Biochem., 31, No. 5, 763-771 (1988).
Cypriani, et al., Chemical Abstracts, CA 110: 1189 v, 1989.
Cypriani, et al., Chemical Abstracts, 110:69550v, 1989.
American Chemical Society, Registry, RN#63676-25-5, 1989.
Black Larry J.
Bryant Henry U.
Cullinan George J.
Eli Lilly and Company
Sales James J.
Wu Shean C.
LandOfFree
Sulfonate and carbamate derivatives of 3-aroylbenzo[b] thiophene does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sulfonate and carbamate derivatives of 3-aroylbenzo[b] thiophene, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sulfonate and carbamate derivatives of 3-aroylbenzo[b] thiophene will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1974301